|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||35.19 - 36.51|
|52-week range||30.98 - 41.30|
|Beta (5Y monthly)||0.73|
|PE ratio (TTM)||9.58|
|Forward dividend & yield||3.00 (8.47%)|
|Ex-dividend date||23 Dec 2021|
|1y target est||N/A|
Altria (MO) strives to expand IQOS and on! amid consumers' rising preference on low-risk tobacco alternatives. Moreover, strong pricing for tobacco products is driving revenues.
The U.S. International Trade Commission recently ruled Philip Morris International's (NYSE: PM) IQOS heated tobacco device violates two patents held by rival British American Tobacco (NYSE: BTI) and that the electronic cigarettes can't be imported or sold in the U.S. While the ruling is obviously a major blow to the tobacco giant because the U.S. is potentially the world's biggest, most lucrative market for e-cigs and IQOS is so far the only e-cig that has earned a modified-risk label from the Food and Drug Administration, the decision is a devastating blow to Philip Morris partner Altria (NYSE: MO) because it has no vapor products to fall back on and no other markets it can sell into.
The ruling before International Trade Commission will halt imports of the electronic cigarette into the U.S.